GemPharmatech Co., Ltd., a contract research organization, provides genetically engineered mouse models and preclinical research services to the scientific community worldwide. The company offers mouse models, including knockout and conditional knockout mouse, knock-in mouse, point-mutation mouse, transgenic mouse, immunodeficient mouse, germ-free mouse, and tool mice models, as well as operates wild mouse project. It also provides custom model generation, preclinical testing, germ-free and microbiome, cell lines and customization, custom breeding, animal quality testing, and other services. The company has a strategic alliance with Memorial Sloan Kettering Cancer Center (MSK) to accelerate the discovery of new therapeutic antibodies. The company was founded in 2017 and is headquartered in Nanjing, China.
Name | Title | Since | Age |
|---|---|---|---|
| Xiang Gao | President & Chairman of the Board | 2017 | 63 |
| Jing Zhao | GM & Director | 2018 | 45 |
| Zhongyu Li | Deputy GM & Director | 2018 | 62 |
| Tao Wang | Deputy GM & Director | 2023 | 41 |
| Bo Yu | Independent Director | 2020 | 56 |
| Bin-Qing Xiao | Independent Director | 2020 | 47 |
| Juan Du | Independent Director | 2020 | 44 |
| Cunxiang Ju | Chairman of the Board of Supervisors | 2009 | 42 |
| Minmin Yang | Director | 2023 | 54 |
| Derong Leng | Director | 2023 | 63 |
| Tao Wen | Supervisor | 2020 | 47 |
| Huixin Yang | Employee Representative Supervisor | 2020 | 45 |